C-reactive protein and the risk of cancer: a mendelian randomization study.

Abstract excerpt

Elevated plasma levels of C-reactive protein (CRP), a marker of inflammation, are associated with an increased risk of cancer, but it is unclear whether this association is causal. We examined whether four common single-nucleotide polymorphisms (SNPs) in the CRP gene that are associated with altered plasma CRP levels are causally associated with an increased risk of cancer. The study population included...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Inflammation
• Share to C-Reactive Protein
• Share to Cross-Sectional Studies